Reprogrammed glucose metabolism in vascular smooth muscle cells and its implications for vascular diseases
Pharmacological Research · 2025
DOI: 10.1016/j.phrs.2025.107995 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2025. Verfasst von Qian Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Ophthalmology, Medicine, and Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Muscle, Smooth, Vascular, Glucose, Myocytes, Smooth Muscle, Vascular Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH National Institutes of Health, American Heart Association.
Abstract (Originalsprache)
Vascular smooth muscle cells (VSMCs) play a pivotal role in maintaining vascular homeostasis and are critical contributors to the pathogenesis of various vascular diseases, including atherosclerosis, calcification, aneurysms, and pulmonary hypertension. Emerging evidence highlights the significance of glucose metabolism in regulating VSMC phenotypic transitions during these pathologies. This review provides a comprehensive overview of the major glucose metabolic pathways in VSMCs, glycolysis, the pentose phosphate pathway (PPP), and the hexosamine biosynthetic pathway (HBP), and their roles in disease development. We summarize the molecular mechanisms linking glucose metabolic reprogramming to VSMC dysfunction, focusing on key regulatory enzymes and signaling pathways. Additionally, we discuss the translational potential of targeting glucose metabolism in VSMCs for therapeutic intervention and the challenges associated with this approach. By underscoring the metabolic shifts underlying VSMC pathophysiology, this review aims to advocate further research into VSMC glucose metabolism as a promising avenue for novel vascular disease treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Ophthalmology, Medicine, and Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
- Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794, USA.
- Rowan-Virtua School of Osteopathic Medicine, Stratford, NJ 08084, USA.
- Institute of Endocrine and Metabolic Diseases, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China.
- Departments of Ophthalmology, Medicine, and Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: Yuqing.Huo@bcm.edu.
Förderung
- NEI NIH HHS
- NIH National Institutes of Health
- American Heart Association
- NHLBI NIH HHS
- National Eye Institute
- National Institutes of Health
- American Heart Association Inc
- National Heart Lung and Blood Institute
Zitieren
APA
Ma, Q., Cai, Y., Yang, Q., Zhang, W., Xu, S., & Huo, Y. (2025). Reprogrammed glucose metabolism in vascular smooth muscle cells and its implications for vascular diseases. Pharmacological Research. https://doi.org/10.1016/j.phrs.2025.107995
Vancouver
Ma Q, Cai Y, Yang Q, Zhang W, Xu S, Huo Y. Reprogrammed glucose metabolism in vascular smooth muscle cells and its implications for vascular diseases. Pharmacological Research. 2025. doi:10.1016/j.phrs.2025.107995
BibTeX
@article{Ma2025,
author = {Ma, Qian and Cai, Yongfeng and Yang, Qiuhua and Zhang, Wendy and Xu, Suowen and Huo, Yuqing},
title = {Reprogrammed glucose metabolism in vascular smooth muscle cells and its implications for vascular diseases},
journal = {Pharmacological Research},
year = {2025},
doi = {10.1016/j.phrs.2025.107995}
}
EUVIMED